Medicare Most-Favored-Nation Drug Pricing Model Faces Legal Challenge

A lawsuit was recently filed against CMS's new GLOBE Medicare drug pricing model, arguing that the agency lacks statutory authority to impose international reference pricing through a demonstration program.